![Neil Aubuchon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Aubuchon
Corporate Officer/Principal chez
VIKING THERAPEUTICS, INC.
Fortune : 146 512 $ au 31/05/2026
Profil
Neil Aubuchon is Chief Commercial Officer at Viking Therapeutics, Inc. since 2026.
Former roles include Global Marketing Lead-General Medicine at Amgen, Inc., Vice President-Global Marketing at Santen, Inc., Chief Marketing Officer at Eli Lilly Japan KK, Chief Commercial Officer at AbCellera Biologics, Inc., and Chief Marketing Officer at Eli Lilly Australia Pty Ltd. Education includes an MBA from the University of Toronto and an undergraduate degree from the University of Western Ontario.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/03/2026 | 4 475 ( 0 % ) | 146 512 $ | 31/05/2026 |
Postes actifs de Neil Aubuchon
| Sociétés | Poste | Début |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Corporate Officer/Principal | 07/01/2026 |
Anciens postes connus de Neil Aubuchon
| Sociétés | Poste | Fin |
|---|---|---|
Eli Lilly Japan KK
 Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Manufactures and trades pharmaceutical products | Sales & Marketing | - |
Eli Lilly Australia Pty Ltd.
 Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Sales & Marketing | - |
| AMGEN INC. | Sales & Marketing | - |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products | Corporate Officer/Principal | - |
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | - |
Formation de Neil Aubuchon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products | Health Technology |
Eli Lilly Japan KK
Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Manufactures and trades pharmaceutical products | Health Technology |
Eli Lilly Australia Pty Ltd.
Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
